hexamethonium has been researched along with Cough in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HILLS, BR | 1 |
KELLY, JC | 1 |
Bolser, DC | 1 |
DeGennaro, FC | 1 |
O'Reilly, S | 1 |
Hey, JA | 1 |
Chapman, RW | 1 |
2 other studies available for hexamethonium and Cough
Article | Year |
---|---|
Effect of hexamethonium iodide on lobeline-stimulated coughing.
Topics: Bis-Trimethylammonium Compounds; Cough; Hexamethonium; Humans; Lobeline | 1951 |
Pharmacological studies of allergic cough in the guinea pig.
Topics: Administration, Oral; Aerosols; Albuterol; Analysis of Variance; Animals; Antitussive Agents; Capsai | 1995 |